← Open Payments lookup

MARYAM NISA: Open Payments

NPI 1992284095 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,894 in 89 payments from 19 companies in 2025. Trend: 2023 $1,519 · 2024 $2,409 · 2025 $1,894

Food & beverage: $1,894
CompanyPaymentsAmount
ABBVIE INC.22$422
Takeda Pharmaceuticals U.S.A., Inc.8$211
GENZYME CORPORATION7$197
Janssen Biotech, Inc.8$193
Madrigal Pharmaceuticals9$170
PFIZER INC.8$146
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$103
Ardelyx, Inc.4$76
Celltrion USA Inc.3$59
Ipsen Biopharmaceuticals, Inc2$58

Products named: DUPIXENT, TREMFYA, ENTYVIO, REZDIFFRA, CREON, SKYRIZI, XIFAXAN, XELJANZ.

Industry payments across MD — which companies pay providers there.